Skip to content
Subscriber Only

Allergan, J&J Breast Implants May Add to Cancer Risk

Allergan Inc. and Johnson & Johnson breast implants were linked in a U.S. review to a rare type of cancer, challenging again the safety of the decades-old products.

About 60 cases of anaplastic large-cell lymphoma have been reported globally in women with breast implants, including 34 published in studies from January 1997 to May 2010, the Food and Drug Administration said today in a notice. Doctors should consider the possibility of cancer in patients with late onset symptoms, including pain, lumps or swelling, the FDA said.